Literature DB >> 18686716

Mesothelioma mortality in Brazil, 1980-2003.

Francisco Pedra1, Anamaria Testa Tambellini, Basílio de Bragança Pereira, Ana Carolina Carioca da Costa, Hermano Albuquerque de Castro.   

Abstract

Although asbestos causes asbestosis, lung cancer, and mesothelioma, it remains widely used in Brazil, mostly in cement-fiber products. We report the Brazilian mesothelioma mortality trend 1980-2003, using records of the national System of Mortality Information of DATASUS, including all deaths with IX International Disease Classification (ICD9) codes 163.n--pleura cancer during the period 1980-1995; and ICD10 codes c45.n--mesotheliomas and c38.4--pleura cancer for the years 1996-2003. Mesothelioma mortality rates increased over the period studied, from 0.56 to 1.01 deaths per 1,000,000 [corrected] habitants. The total number of mesothelioma deaths nationwide in the period studied was 2,414; the majority (1,415) were in the Southeast region. Mortality was highest among males and people over age 65. Given the history of asbestos exposure in Brazil, our findings support the need for policies that limit or ban the use of this product.

Entities:  

Mesh:

Year:  2008        PMID: 18686716     DOI: 10.1179/oeh.2008.14.3.170

Source DB:  PubMed          Journal:  Int J Occup Environ Health        ISSN: 1077-3525


  10 in total

1.  Estimating the incidence of malignant mesothelioma in Vietnam: a pilot descriptive cancer registration study.

Authors:  Matthew J Soeberg; Mai Anh Luong; Van Thuan Tran; Anh Thanh Tran; Thị Thu Huyen Nguyen; Dieu Bui; Thi Hoai Nga Nguyen; Ken Takahashi; Nico van Zandwijk
Journal:  Int J Occup Environ Health       Date:  2016-07-08

2.  Surveillance for occupational respiratory diseases in developing countries.

Authors:  Vinicius C Antao; Germania A Pinheiro
Journal:  Semin Respir Crit Care Med       Date:  2015-05-29       Impact factor: 3.119

Review 3.  The function, mechanisms, and role of the genes PTEN and TP53 and the effects of asbestos in the development of malignant mesothelioma: a review focused on the genes' molecular mechanisms.

Authors:  Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  Tumour Biol       Date:  2013-10-01

4.  Comments on the introduction of the paper "Overview of the biochemical and genetic processes in malignant mesothelioma".

Authors:  Algranti Eduardo
Journal:  J Bras Pneumol       Date:  2014-10       Impact factor: 2.624

Review 5.  Prevention of Asbestos Exposure in Latin America within a Global Public Health Perspective.

Authors:  Eduardo Algranti; Juan Pablo Ramos-Bonilla; Benedetto Terracini; Vilma S Santana; Pietro Comba; Roberto Pasetto; Agata Mazzeo; Fulvio Cavariani; Andrés Trotta; Daniela Marsili
Journal:  Ann Glob Health       Date:  2019-03-29       Impact factor: 2.462

6.  How Malignant Mesothelioma Was Coded in Mortality Data in Taiwan During Years When the Specific ICD Code Was Not Available?

Authors:  Shu-Yu Tai; Jingyi Wu; Lukas Jyuhn-Hsiarn Lee; Tsung-Hsueh Lu
Journal:  Clin Epidemiol       Date:  2021-12-24       Impact factor: 4.790

Review 7.  Malignant pleural mesothelioma: an update.

Authors:  Glaucia N M Hajj; Carolina H Cavarson; Clóvis Antônio Lopes Pinto; Gabriela Venturi; João R Navarro; Vladmir C Cordeiro de Lima
Journal:  J Bras Pneumol       Date:  2021-12-13       Impact factor: 2.800

8.  Are current or future mesothelioma epidemics in Hong Kong the tragic legacy of uncontrolled use of asbestos in the past?

Authors:  Lap Ah Tse; Ignatius Tak-sun Yu; William Goggins; Mark Clements; Xiao Rong Wang; Joseph Siu-kie Au; Kai Shing Yu
Journal:  Environ Health Perspect       Date:  2009-10-22       Impact factor: 9.031

Review 9.  Overview of the biochemical and genetic processes in malignant mesothelioma.

Authors:  Leonardo Vinícius Monteiro de Assis; Mauro César Isoldi
Journal:  J Bras Pneumol       Date:  2014 Jul-Aug       Impact factor: 2.624

Review 10.  Prevention of Asbestos-Related Disease in Countries Currently Using Asbestos.

Authors:  Daniela Marsili; Benedetto Terracini; Vilma S Santana; Juan Pablo Ramos-Bonilla; Roberto Pasetto; Agata Mazzeo; Dana Loomis; Pietro Comba; Eduardo Algranti
Journal:  Int J Environ Res Public Health       Date:  2016-05-12       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.